The winners of the CPHI Pharma Awards 2026 include a neurodegeneration platform, a track-and-trace packaging innovation, a enzymatic mRNA manufacturing technology, and a cell-free enzymatic biomanufacturing platform.
|Articles|October 9, 2014
Laser Marks Pills at High Speeds
Laser-marking speed exceeds 410,000 pharmaceutical pills per hour.
Lasers are used in the marking of unique identification (e.g., text, logos, graphics, and barcodes) on pharmaceutical packaging and for direct pill marking. Laser-marking of pills is simple and high speed, without the solvents needed for traditional pill marking methods. The LMCP-100 Extreme Laser from Photoscribe Technologies micro-marks pills at speeds exceeding 410,000 pills per hour. The laser has the ability to serialize and change a mark on the fly during the marking process. The speed and flexibility allow the user to change marks based on batch number or even down to the single pill level.
Source:
Related to this article
Richard Jaenisch explains why NAMs are compressing drug development faster than AI and what FDA's new nonclinical testing rule means for sponsors.
Hovione's $35M CDC Flex line links spray drying to tablets, designed to eliminate scale-up under FDA Q13 guidance.
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
Ron Scarboro, Azurity Pharmaceuticals, claims drug reformulation that removes patient barriers must preserve efficacy, urging early cross-functional team alignment.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.